• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONCORD MANUFACTURING LIBERTY SELECT CYCLER ASSY(NON-VALUATED); SYSTEM, PERITONEAL, AUTOMATIC DELIVERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONCORD MANUFACTURING LIBERTY SELECT CYCLER ASSY(NON-VALUATED); SYSTEM, PERITONEAL, AUTOMATIC DELIVERY Back to Search Results
Catalog Number RTLR180343
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Peritonitis (2252)
Event Date 01/01/2023
Event Type  Injury  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.Clinical investigation: it is unknown if a temporal relationship exists between ccpd therapy utilizing the liberty select cycler, liberty cycler set and the serious adverse events of an stemi (requiring hospitalization) and peritonitis, which reportedly required the patient to transition to another form of rrt.The etiology and timeline of events is unknown; therefore, causality cannot be established.However, the pdrn¿s response did not indicate a fresenius device(s) and/or product(s) malfunctioned or was deficient in any way.Myocardial infarctions are a widespread complication for patients undergoing maintenance dialysis due to their underlying and often complex cardiovascular and endocrine status.Additionally, those individuals undergoing pd therapy (manual or cycler based) are at high risk for infections of the peritoneum.Based on the information available, the liberty select cycler and liberty cycler set can be disassociated from the serious adverse events.There is no allegation or objective evidence indicating a fresenius device(s) and/or product(s) caused and/or contributed to the serious adverse events.Furthermore, there was no report a fresenius product(s) and/or device(s) failed to meet the users¿ expectations or manufacturers¿ specifications.
 
Event Description
On 08/08/2023, fresenius became aware this patient with end stage renal disease (esrd) on continuous cyclic peritoneal dialysis [cc(pd)] for renal replacement therapy (rrt) was hospitalized.During intake, the pd registered nurse (pdrn) reported the patient contracted peritonitis while hospitalized and is no longer able to perform pd therapy.A written response from the patient¿s pdrn revealed the patient was hospitalized (admission date not provided, >30-day hospitalization) due to a st elevation myocardial infarction (stemi).It was reported the patient developed peritonitis while admitted and required transition to alternate form of rrt (modality type not provided).As of (b)(6) 2023, the patient remained hospitalized and is recovering from the serious adverse events.Additional information (e.G., hospital records, medication records, treatment records) was requested, however the patient¿s medical record was closed.The patient was discharged from the outpatient home program after being hospitalized for >30 days.Additional information was requested however the request could not be fulfilled as the patient¿s electronic medical record was closed.
 
Manufacturer Narrative
Plant investigation: no parts were returned to the manufacturer for physical evaluation.A records review was performed on the reported serial number.An investigation of the device manufacturing records was conducted by the manufacturer.There were no non-conformances, or any associated rework identified during the manufacturing process which could be related to the reported event.In addition, the device history record (dhr) review confirmed the results of the in-progress and final quality control (qc) testing met all requirements.The investigation into the cause of the reported problem was not able to be confirmed.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.
 
Event Description
On 08/08/2023, fresenius became aware this patient with end stage renal disease (esrd) on continuous cyclic peritoneal dialysis [cc(pd)] for renal replacement therapy (rrt) was hospitalized.During intake, the pd registered nurse (pdrn) reported the patient contracted peritonitis while hospitalized and is no longer able to perform pd therapy.A written response from the patient¿s pdrn revealed the patient was hospitalized (admission date not provided, >30-day hospitalization) due to a st elevation myocardial infarction (stemi).It was reported the patient developed peritonitis while admitted and required transition to alternate form of rrt (modality type not provided).As of (b)(6) 2023, the patient remained hospitalized and is recovering from the serious adverse events.Additional information (e.G., hospital records, medication records, treatment records) was requested, however the patient¿s medical record was closed.The patient was discharged from the outpatient home program after being hospitalized for >30 days.Additional information was requested however the request could not be fulfilled as the patient¿s electronic medical record was closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIBERTY SELECT CYCLER ASSY(NON-VALUATED)
Type of Device
SYSTEM, PERITONEAL, AUTOMATIC DELIVERY
Manufacturer (Section D)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer (Section G)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key17625135
MDR Text Key321971892
Report Number0002937457-2023-01284
Device Sequence Number1
Product Code FKX
UDI-Device Identifier00840861102068
UDI-Public00840861102068
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K181108
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 10/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/25/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberRTLR180343
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Date Manufacturer Received09/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/02/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
DELFLEX PD FLUID; DELFLEX PD FLUID; LIBERTY CYCLER SET; LIBERTY CYCLER SET
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age75 YR
Patient SexFemale
Patient Weight62 KG
-
-